Yuan Li

机构：East China University of Science and Technology, China Pharmaceutical University, Shanghai Jiao Tong University, Taiwan Centers for Disease Control · ORCID：0000-0001-5651-819X

发表论文 855 篇 · 总被引 18019 次 · h-index 66

代表论文

• Dissecting macrophage heterogeneity in ulcerative colitis: Single-cell analysis and functional validation of S100A4 as a therapeutic target (2025 · International Immunopharmacology · 被引 7)
• Quantitative proteomic analysis of pathological and physiological ovarian aging: model evaluation, molecular mechanisms, and identification of early biomarkers and therapeutic targets (2025 · Journal of Ovarian Research · 被引 6)
• MA01.05 Tislelizumab Plus Chemotherapy Followed by Surgery or Radiotherapy and Adjuvant Tislelizumab in Unresectable Stage III NSCLC (2025 · Journal of Thoracic Oncology · 被引 2)
• Solute carrier family 2 member 3: A central mediator in aerobic glycolysis contributing to tumor malignant progression (2025 · International Journal of Cancer · 被引 2)
• Study of the blood–brain barrier-penetrating KRAS G12C inhibitor JMKX1899 in KRAS G12C-mutated NSCLC with brain metastases (2025 · Journal of the National Cancer Center · 被引 1)
• Cost-effectiveness of PD-L1 testing to guide immunotherapy for patients with advanced non-small-cell lung cancer in China (2025 · Journal of Comparative Effectiveness Research · 被引 1)